PL2419086T3 - Biodostępne kompozycje amorficznego związku alfa-(N-sulfonamido)acetamidu - Google Patents
Biodostępne kompozycje amorficznego związku alfa-(N-sulfonamido)acetamiduInfo
- Publication number
- PL2419086T3 PL2419086T3 PL10714413T PL10714413T PL2419086T3 PL 2419086 T3 PL2419086 T3 PL 2419086T3 PL 10714413 T PL10714413 T PL 10714413T PL 10714413 T PL10714413 T PL 10714413T PL 2419086 T3 PL2419086 T3 PL 2419086T3
- Authority
- PL
- Poland
- Prior art keywords
- sulfonamido
- acetamide compound
- amorphous alpha
- bioavailable compositions
- bioavailable
- Prior art date
Links
- -1 acetamide compound Chemical class 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- DLFVBJFMPXGRIB-UHFFFAOYSA-N thioacetamide Natural products CC(N)=O DLFVBJFMPXGRIB-UHFFFAOYSA-N 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4245—Oxadiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US16906609P | 2009-04-14 | 2009-04-14 | |
| PCT/US2010/030679 WO2010120662A2 (en) | 2009-04-14 | 2010-04-12 | Bioavailable compositions of amorphous alpha-(n-sulfonamido)acetamide compound |
| EP10714413.1A EP2419086B1 (en) | 2009-04-14 | 2010-04-12 | Bioavailable compositions of amorphous alpha-(n-sulfonamido)acetamide compound |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2419086T3 true PL2419086T3 (pl) | 2013-11-29 |
Family
ID=42664672
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL10714413T PL2419086T3 (pl) | 2009-04-14 | 2010-04-12 | Biodostępne kompozycje amorficznego związku alfa-(N-sulfonamido)acetamidu |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US20100261768A1 (pl) |
| EP (1) | EP2419086B1 (pl) |
| JP (1) | JP2012524090A (pl) |
| KR (1) | KR20120027142A (pl) |
| CN (1) | CN102387788B (pl) |
| AR (1) | AR076306A1 (pl) |
| AU (1) | AU2010236701A1 (pl) |
| BR (1) | BRPI1012523A2 (pl) |
| CA (1) | CA2758709A1 (pl) |
| DK (1) | DK2419086T3 (pl) |
| EA (1) | EA201171207A1 (pl) |
| ES (1) | ES2426403T3 (pl) |
| HR (1) | HRP20130807T1 (pl) |
| MX (1) | MX2011010513A (pl) |
| NZ (1) | NZ595411A (pl) |
| PL (1) | PL2419086T3 (pl) |
| PT (1) | PT2419086E (pl) |
| SI (1) | SI2419086T1 (pl) |
| SM (1) | SMT201300106B (pl) |
| TW (1) | TW201043269A (pl) |
| WO (1) | WO2010120662A2 (pl) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2471099C (en) | 2001-12-20 | 2011-04-12 | Bristol-Myers Squibb Company | .alpha.-(n-sulphonamido)acetamide derivatives as .beta.-amyloid inhibitors |
| US8044077B2 (en) | 2009-03-19 | 2011-10-25 | Bristol-Myers Squibb Company | Alpha-(N-sulfonamido)acetamide compounds incorporating deuterium as inhibitors of beta amyloid peptide production |
| US7977362B2 (en) | 2009-03-20 | 2011-07-12 | Bristol-Myers Squibb Company | Alpha-(N-benzenesulfonamido)cycloalkyl derivatives |
| US8252821B2 (en) | 2009-04-14 | 2012-08-28 | Bristol-Myers Squibb Company | Bioavailable capsule compositions of amorphous alpha-(N-sulfonamido)acetamide compound |
| EP2734190A1 (en) * | 2011-07-21 | 2014-05-28 | Bristol-Myers Squibb Company | Bioavailable compositions of amorphous piperidinyl compounds |
| US20150045353A1 (en) * | 2013-08-09 | 2015-02-12 | Neurogenetic Pharmaceuticals, Inc. | Formulations containing gamma secretase modulators, methods for preparation and delivery thereof |
| TWI803187B (zh) * | 2014-08-08 | 2023-05-21 | 日商中外製藥股份有限公司 | 包含４環性化合物的非晶質體之固體分散體及製劑 |
Family Cites Families (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3999007A (en) * | 1975-10-09 | 1976-12-21 | Carl Joseph Crane | Aircraft visual approach/landing reproducer device and system |
| US5136301A (en) * | 1989-08-30 | 1992-08-04 | Rockwell International Corporation | Primary flight display system having a vertical linear altimeter |
| US5274094A (en) * | 1990-08-15 | 1993-12-28 | British Bio-Technology Limited | Production of heterobicyclic containing benzene sulfonamides |
| GB9202791D0 (en) * | 1992-02-11 | 1992-03-25 | British Bio Technology | Compounds |
| EP0750238B1 (en) * | 1995-06-20 | 2000-03-01 | Honeywell Inc. | Integrated ground collision avoidance system |
| SK282833B6 (sk) * | 1995-11-17 | 2002-12-03 | Warner-Lambert Company | Sulfónamidové inhibítory matricových metaloproteináz a farmaceutická kompozícia obsahujúca tieto inhibítory |
| EP1093564B1 (en) * | 1998-07-06 | 2006-11-08 | Honeywell International Inc. | Aircraft position validation using radar and digital terrain elevation database |
| US6313123B1 (en) * | 1999-01-27 | 2001-11-06 | American Cyanamid Company | Acetylenic sulfonamide thiol tace inhibitors |
| US6570531B1 (en) * | 2000-04-27 | 2003-05-27 | Rockwell Collins, Inc. | Satellite navigation receiver designed for compatibility with aircraft automatic landing systems |
| US6483454B1 (en) * | 2000-11-28 | 2002-11-19 | Bae Systems Aerospace Inc. | Close formation aircraft collision avoidance |
| CA2471099C (en) * | 2001-12-20 | 2011-04-12 | Bristol-Myers Squibb Company | .alpha.-(n-sulphonamido)acetamide derivatives as .beta.-amyloid inhibitors |
| KR20060002908A (ko) * | 2003-03-31 | 2006-01-09 | 와이어쓰 | 베타 아밀로이드 생산 억제제인 플루오로- 및트리플루오로알킬-함유 헤테로사이클릭 설폰아미드 및 이의유도체 |
| US20050048112A1 (en) * | 2003-08-28 | 2005-03-03 | Jorg Breitenbach | Solid pharmaceutical dosage form |
| FR2870605B1 (fr) * | 2004-05-18 | 2010-10-08 | Airbus France | Procede et dispositif de guidage automatique d'un aeronef, pour un vol au moins en partie a basse altitude |
| FR2880456B1 (fr) * | 2005-01-03 | 2007-02-23 | Airbus France Sas | Procede et dispositif d'alerte sonore lors de la desactivation d'un pilote automatique d'un aeronef |
| FR2886439B1 (fr) * | 2005-05-24 | 2010-11-05 | Eurocopter France | Procede et dispositif d'aide au pilotage d'un aeronef a basse altitude |
| CA2626802A1 (en) * | 2005-11-09 | 2007-09-20 | Novartis Ag | Process for making pharmaceutical compositions with a transient plasticizer |
| FR2897448B1 (fr) * | 2006-02-14 | 2008-03-14 | Airbus France Sas | Procede et systeme d'aide au pilotage d'un aeronef. |
| EP1984321A1 (en) * | 2006-02-17 | 2008-10-29 | Wyeth | Methods for preparing sulfonamide substituted alcohols and intermediates thereof |
| AR059517A1 (es) * | 2006-02-17 | 2008-04-09 | Wyeth Corp | N- sulfonilacion selectiva de alcoholes sustituidos con 2- aminotrifluoralquilo |
| CA2645566A1 (en) * | 2006-03-20 | 2007-09-27 | Vertex Pharmaceuticals Incorporated | Pharmaceutical compositions |
| WO2007109605A2 (en) * | 2006-03-20 | 2007-09-27 | Vertex Pharmaceuticals Incorporated | Pharmaceutical compositions |
| FR2911988B1 (fr) * | 2007-01-26 | 2016-03-25 | Airbus France | Procede et dispositif pour determiner une hauteur maximale de stabilisation lors de la phase finale de vol d'un avion |
| US8084477B2 (en) * | 2007-10-31 | 2011-12-27 | Bristol-Myers Squibb Company | Alpha-(N-sulfonamido)acetamide compound as an inhibitor of beta amyloid peptide production |
-
2010
- 2010-04-08 TW TW099110918A patent/TW201043269A/zh unknown
- 2010-04-09 US US12/757,304 patent/US20100261768A1/en not_active Abandoned
- 2010-04-12 KR KR1020117024035A patent/KR20120027142A/ko not_active Withdrawn
- 2010-04-12 NZ NZ595411A patent/NZ595411A/xx not_active IP Right Cessation
- 2010-04-12 EA EA201171207A patent/EA201171207A1/ru unknown
- 2010-04-12 SI SI201030355T patent/SI2419086T1/sl unknown
- 2010-04-12 PT PT107144131T patent/PT2419086E/pt unknown
- 2010-04-12 EP EP10714413.1A patent/EP2419086B1/en not_active Not-in-force
- 2010-04-12 HR HRP20130807AT patent/HRP20130807T1/hr unknown
- 2010-04-12 JP JP2012506089A patent/JP2012524090A/ja active Pending
- 2010-04-12 WO PCT/US2010/030679 patent/WO2010120662A2/en not_active Ceased
- 2010-04-12 CN CN2010800160778A patent/CN102387788B/zh not_active Expired - Fee Related
- 2010-04-12 PL PL10714413T patent/PL2419086T3/pl unknown
- 2010-04-12 AU AU2010236701A patent/AU2010236701A1/en not_active Abandoned
- 2010-04-12 ES ES10714413T patent/ES2426403T3/es active Active
- 2010-04-12 CA CA2758709A patent/CA2758709A1/en not_active Abandoned
- 2010-04-12 MX MX2011010513A patent/MX2011010513A/es unknown
- 2010-04-12 BR BRPI1012523A patent/BRPI1012523A2/pt not_active Application Discontinuation
- 2010-04-12 DK DK10714413.1T patent/DK2419086T3/da active
- 2010-04-14 AR ARP100101258A patent/AR076306A1/es unknown
-
2013
- 2013-09-24 SM SM201300106T patent/SMT201300106B/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EA201171207A1 (ru) | 2012-03-30 |
| BRPI1012523A2 (pt) | 2016-03-29 |
| JP2012524090A (ja) | 2012-10-11 |
| HRP20130807T1 (hr) | 2013-09-30 |
| EP2419086A2 (en) | 2012-02-22 |
| AR076306A1 (es) | 2011-06-01 |
| TW201043269A (en) | 2010-12-16 |
| CA2758709A1 (en) | 2010-10-21 |
| WO2010120662A3 (en) | 2011-09-15 |
| AU2010236701A1 (en) | 2011-10-20 |
| NZ595411A (en) | 2013-02-22 |
| MX2011010513A (es) | 2011-11-29 |
| EP2419086B1 (en) | 2013-06-26 |
| KR20120027142A (ko) | 2012-03-21 |
| WO2010120662A2 (en) | 2010-10-21 |
| SI2419086T1 (sl) | 2013-10-30 |
| SMT201300106B (it) | 2013-11-08 |
| PT2419086E (pt) | 2013-09-04 |
| DK2419086T3 (da) | 2013-09-30 |
| ES2426403T3 (es) | 2013-10-23 |
| US20100261768A1 (en) | 2010-10-14 |
| CN102387788B (zh) | 2013-07-10 |
| CN102387788A (zh) | 2012-03-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SI2295417T1 (sl) | Novi intermediati uporabni za pripravo alfa n sulfonamid acetamidne spojine | |
| EP2427999A4 (en) | Sanitization of packets | |
| IL210322A (en) | A crystalline form of sitagliptin malate | |
| PL2280916T3 (pl) | Kompozycje chlorofluorowodoroolefin | |
| IL248056B (en) | Compounds of polymeric myrcene | |
| SI2419086T1 (sl) | Biološko sprejemljivi sestavki amorfne alfa-(N-sulfonamid)acetamidne spojine | |
| GB0906281D0 (en) | Detergent compositions | |
| PL2340960T3 (pl) | Przedział stanu naładowania | |
| PL2238094T3 (pl) | Odwadnianie alkoholi na krystalicznych krzemianach | |
| IL205130A0 (en) | Solid formulations of crystalline compounds | |
| GB0915572D0 (en) | Detergent composition | |
| ZA201105045B (en) | Crystalline forms of genistein | |
| ZA201008641B (en) | Crystalline modifications of prothioconazole | |
| EP2376561A4 (en) | AMORPHIC MICROPOROUS ORGANOSILICATE COMPOSITIONS | |
| IL244350A0 (en) | Pharmaceutical preparation of amorphous acyl sulfonamide | |
| ZA201109045B (en) | Crystalline form of pemirolast | |
| ZA201106206B (en) | A novel alpha-(n-sulfonamido)acetamide compound as an inhibitor of beta amyloid peptide production | |
| ZA201202097B (en) | Crystalline forms of substituted pyrazolopyrimidines | |
| EP2512247A4 (en) | NOVEL THIOPHEN INHIBITORS OF S-NITROSOGLUTATHIONE REDUCTASE | |
| HK1161131A (en) | Bioavailable compositions of amorphous alpha-(n-sulfonamido)acetamide compound | |
| ZA201007397B (en) | Delayed release compositions of duloxetine | |
| ZA201004762B (en) | Crystalline form of abacavir that is essentially free of solvent | |
| HK1161132A (en) | Bioavailable capsule compositions of amorphous alpha-(n-sulfonamido)acetamide compound | |
| TWM371616U (en) | Improved mechanism for adjusting torque of wrench | |
| PL2408799T3 (pl) | Nowa krystaliczna postać anty-progesteronu CDB-4124 |